Hennessy D R, Lacey E, Prichard R K, Steel J W
J Vet Pharmacol Ther. 1985 Sep;8(3):270-5. doi: 10.1111/j.1365-2885.1985.tb00956.x.
The ability of parbendazole (PBZ) to potentiate co-administered oxfendazole (OFZ) was investigated. Administration of a range (1.35-36.0 mg/kg) of doses of PBZ with 4.53 mg OFZ/kg demonstrated that significant potentiation occurred at 4.5 mg PBZ/kg. At 4.5 mg PBZ/kg, the area under the plasma OFZ concentration curve was about twice that obtained from oral administration of OFZ alone. When tested against benzimidazole-resistant Haemonchus contortus and Trichostrongylus colubriformis, the mixture of 4.5 mg PBZ + 4.53 mg OFZ/kg was significantly more effective than 4.53 mg OFZ/kg alone, and PBZ alone showed no activity against these resistant nematodes. The demonstration of PBZ-OFZ potentiation has indicated a means of obtaining a more effective use of currently available anthelmintics in the treatment of helminthiasis.
研究了帕苯达唑(PBZ)增强联合使用的奥芬达唑(OFZ)的能力。将一系列剂量(1.35 - 36.0毫克/千克)的PBZ与4.53毫克OFZ/千克联合给药,结果表明在4.5毫克PBZ/千克时出现显著的增强作用。在4.5毫克PBZ/千克时,血浆OFZ浓度曲线下面积约为单独口服OFZ时的两倍。当针对对苯并咪唑耐药的捻转血矛线虫和蛇形毛圆线虫进行测试时,4.5毫克PBZ + 4.53毫克OFZ/千克的混合物比单独使用4.53毫克OFZ/千克显著更有效,并且单独的PBZ对这些耐药线虫没有活性。PBZ - OFZ增强作用的证明表明了一种在治疗蠕虫病中更有效利用现有驱虫药的方法。